Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Dammam University
Sponsor:
Collaborators:
King Fahad Armed Forces Hospital
Dammam central Hospital
Information provided by (Responsible Party):
Dammam University
ClinicalTrials.gov Identifier:
NCT01823185
First received: March 19, 2013
Last updated: April 2, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)